NCT07244393 2025-11-24Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate CancerCellbion Co., Ltd.Phase 1 Not yet recruiting30 enrolled
NCT06553846 2024-08-14A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid TumorsFudan UniversityPhase 1 Not yet recruiting50 enrolled